Search
for
Sort by
Research 61–90 of 856
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Changes in Expression and Function of Extrasynaptic GABA<sub>A</sub>Receptors in the Rat Hippocampus during Pregnancy and after Delivery
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- The connection of 5-alpha reductase inhibitors to the development of depression
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Hair: What is New in Diagnosis and Management?
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Effect of finasteride on human testicular steroidogenesis.
- Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
- Treatment options for polycystic ovary syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- The gut‐microbiota‐brain axis: Focus on gut steroids
- Metabolic effects of 5α-reductase inhibition in humans
- The profile of steroid hormones in human fetal and adult ovaries
- [Clinical significance of testosterone and dihydrotestosterone metabolism in women].
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Acne
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Clinical biochemistry of dihydrotestosterone
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Inhibitory influence of agmatine on catamenial-like seizure susceptibility in progesterone withdrawn female rats
- Finasteride treatment and neuroactive steroid formation.